- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
Science 37 Funding
$107.5M
44 rounds
Science 37 is active in the following markets / industries: mobile, information technology, health care information technology, software, technology and clinical trials. The company has secured funding across 4 rounds, totaling in an amount of $107.5M. Their most recent funding was raised on March 5, 2018.
Funding Rounds
D
$35000000C
$35000000B
$31000000A
$6500000Investors of Science 37
Glynn Capital
Rounds
C
Amgen Ventures
GV provides venture capital funding to bold new companies
Sanofi Genzyme
Rounds
B
dRx Capital
Rounds
B
A
Lux helps entrepreneurs turn breakthroughs into world-changing companies
Rounds
B
A
Arthur Iinuma
President / Co-Founder @ISBX (4x Inc 500) & @avenue-mobile. Formerly VP @UBS & @Morgan Stanley. Investor in @Science 37 @Soothe @Bambee @Direct Dermatology
